DSS opened lower at $0.51, compared with its previous close of $0.52. In the last trading session, the stock traded between $0.51 and $0.53. It showed an upward intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in DSS is now worth
$ 2.17
resulting in a loss of
$ 97.83 (97.83%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
+$0.02 (+3.25%)
Day High
$0.53
Day Low
$0.51
Day Open
$0.51
Prev Close
$0.52
Volume
1,208
1W Return
-1.29%
1M Return
-23.82%
3M Return
6.59%
6M Return
1.81%
1Y Return
-55.13%
Fundamentals
Market Cap ($ Mn)
5
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-205.61%
ROCE
-76.85%
EPS (TTM)
$-0.48
Investment Returns
1 Week
-1.29%
1 Month
-23.82%
3 Months
6.59%
6 Months
1.81%
9 Months
-51.01%
Financials
Quarterly
All values in $ Mn
5.0
Mar 25
5.3
Jun 25
6.4
Sep 25
4.1
Dec 25
4.3
Mar 26
3.6
Jun 26
Updates
8Sep
DSS Inc launches DSS Robotics for AI-powered enterprise automation
DSS Inc launches DSS Robotics to offer AI-powered automation and RaaS. Unit focuses on enterprise customers for operational task automation. Innovation center planned at Rochester, NY manufacturing facility. Aims to create recurring service opportunities and longer-term relationships.
1mo ago
4Sep
DSS cancels public offering citing limited shelf registration capacity
DSS, Inc. cancels planned public stock offering. Cites limited capacity under existing shelf registration. Aegis Capital Corp was sole book-running manager. Company continues evaluating alternative capital options.
DSS, Inc. withdrew its Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission after a review of market conditions and deal terms. Management and the Board determined that proceeding with the offering would not reflect the value being built for shareholders. The company remains committed to accessing capital markets on suitable terms and continues to advance strategic initiatives, including the merger with Impact Biomedical.
